Founded in 2015 by current CEO Raymond Nomizu and Phuc Truong, CRIO’s goal is to transform the clinical trial industry by reimagining workflows from a site-centric perspective. By automating protocols at the site level, CRIO’s technology builds quality at point of capture, unlocking significant downstream benefits for sites and sponsors alike.
